BioSpace News Archive

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs, announced today that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 10,344,262, for a system for production of antigen presenting dendritic cells from human embryonic stem cells (hESCs).

ReAlta Life Sciences, Inc. is an early stage pharmaceutical company incorporated in late 2018, and located in Norfolk, Virginia. ReAlta was initially formed as a joint venture between Children’s Hospital of The King’s Daughters, Children’s Specialty Group (170 multispecialty pediatricians) and Eastern Virginia Medical School.

NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that management will participate in the following investor events in Septembe

Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today announced the appointment of Monica Forbes as its Chief Financial Officer, effective immediately.

Bringing stem cells into their strategy opens the door for treatments in brain tumors such as Glioblastoma

Johnson & Johnson (NYSE: JNJ) and its Janssen Pharmaceutical Companies today announced they will appeal the $572 million civil judgment entered in Cleveland County District Court in the State of Oklahoma’s lawsuit against opioid manufacturers

SC Johnson does not manufacture or sell pharmaceutical products.

Designed with special features for the storage of fresh frozen tissue samples, Micronic releases the innovative and traceable 1.50ml and 3.00ml Hybridtubes with external thread.